Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study-Reference-Cited by-同舟云学术

Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study

Published:2021-09 Issue: Volume:91 Page:75-80
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

van der Wall Sake J.,Lip Gregory Y.H.^ORCID,Teutsch Christine,Kalejs Oskars,Lyrer Philippe,Hall Christian^ORCID,Dubner Sergio J.^ORCID,Diener Hans-Christoph^ORCID,Halperin Jonathan L.^ORCID,Ma Chang Sheng,Rothman Kenneth J.^ORCID,Zint Kristina,Zhai Dongmei,Huisman Menno V.^ORCID

Funder

Johnson and Johnson

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Sanofi

Schweizerische Herzstiftung

Actelion Pharmaceuticals

University Hospital Foundation

St. Jude Medical

GlaxoSmithKline

Bayer HealthCare

AstraZeneca

Bayer

Abbott Laboratories

Pfizer

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Internal Medicine

Reference29 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS);Hindricks;Eur Heart J,2020

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

3. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study;Airaksinen;J Am Coll Cardiol,2013

4. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy;Hansen;Europace,2015

5. Direct oral anticoagulants halve thromboembolic events after cardioversion of AF compared with warfarin;Kotecha;J Am Coll Cardiol,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study;European Heart Journal - Digital Health;2024-02-20